The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?

Jean-Paul Pirnay (1) , Daniel de Vos (1) , Gilbert Verbeken (1) , Maia Merabishvili (1, 2, 3) , Nina Chanishvili (2) , Mario Vaneechoutte (3) , Martin Zizi (4, 5) , Geert Laire (6) , Rob Lavigne (7) , Isabelle Huys (7) , Guy van den Mooter (7) , Angus Buckling (8) , Laurent Debarbieux (9) , Flavie Pouillot (10) , Joana Azeredo (11) , Elisabeth Kutter (12) , Alain Dublanchet (13) , Andrzej Górski (14) , Revaz Adamia (2)

1 Laboratory for Molecular and Cellular Technology
2 George Eliava Institute of Bacteriophages, Microbiology and Virology [Tbilisi, Georgia]
3 UGENT - Universiteit Gent = Ghent University [Belgium]
4 Brussels Free University
5 Queen Astrid Military Hospital [Brussels]
6 Office of the Surgeon General
7 UCL - Université Catholique de Louvain = Catholic University of Louvain
8 Department of Zoology
9 BMGE - Biologie Moléculaire du Gène chez les Extrêmophiles
10 Pherecydes Pharma
11 Universidade do Minho = University of Minho [Braga]
12 Evergreen State College
13 CHIV - Centre Hospitalier Intercommunal Villeneuve-Saint-Georges
14 Medical University of Warsaw - Poland

Keywords: antibiotic resistance; bacterial infection; bacteriophages; drugs; phage therapy

Domains: Life Sciences [q-bio]

Jean-Paul Pirnay, Daniel de Vos, Gilbert Verbeken, Maia Merabishvili, Nina Chanishvili, et al.. The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?. Pharmaceutical Research, 2010, 28 (4), pp.934 - 937. ⟨10.1007/s11095-010-0313-5⟩. ⟨pasteur-03165353⟩